Results indicated that TFAP2A was positively associated with the HR in KIRC and KIRP yet negatively associated with Ovarian serous cystadenocarcinoma (OV) and UVM (Figure 2A), which would be further studied. The gene discussed is TFAP2A; the disease is ovarian serous cystadenocarcinoma.